ARGINOX PHARMACEUTICALS, INC.

Basic Information

ARGINOX PHARMACEUTICALS, INC.
120 CONSTITUTION DR, STE B
MENLO PARK, CA, 94025

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Therapy for Improving Vascular Function in Diabetes

    Amount: $128,203.00

    DESCRIPTION (provided by applicant): ArgiNOx is a recently-formed Wisconsin-based biotech startup that seeks to develop novel therapies for cardiovascular and inflammatory conditions resulting from in ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. Use of NOS inhibitor to expand hematopoietic stem cells

    Amount: $192,938.00

    DESCRIPTION (provided by applicant): Hematopoietic cell-supported therapy is employed for a broad spectrum of malignancies and hematological disease. However, the approach is limited by the availabili ...

    SBIR Phase I 2004 Department of Health and Human Services
  3. NOS Inhibitor Therapy for Cardiogenic Shock

    Amount: $271,044.00

    DESCRIPTION (provided by applicant): This is a Fast-track Phase I application from ArgiNOx Inc. to develop a novel pharmacotherapy that may save lives of tens of thousands of patients that develop car ...

    SBIR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government